Marisa Wexler, MS, senior science writer —

In a mouse model of Parkinson’s disease animals show signs of inflammation in the gut, and treatment with cell therapies that reduce this inflammation help to ease symptoms of Parkinson’s, according to a new study. These results suggest that inflammatory conditions in the gut may contribute to the development…

The U.S. Food and Drug Administration (FDA) has granted NeuroOne Medical Technologies clearance to market its Evo stereoelectroencephalography (sEEG) electrode technology for temporary use of less than 30 days. The device — previously cleared by the FDA for use of less than one day — is used to measure…

People with Parkinson’s disease have generally positive attitudes toward using therapies derived from human embryos, according to a new study based on interviews with patients in Sweden. The study, “Patients’ views on using human embryonic stem cells to treat Parkinson’s disease: an interview study,” was published in BMC Medical Ethics.

A therapeutic mix of exercise, cognitive stimulation and social activity — known as environmental enrichment — eased Parkinson’s disease symptoms and protected brain cells in a mouse model, though to a greater extent in early disease stages, a study reported. Benefits were notably less potent in animals with more advanced…

Former caregivers could serve as a helpful resource in supporting current caregivers of people with Parkinson’s disease, a study reported. The intent is to “provide guidance for developing peer-to-peer support programs, incorporating former carers,” its researchers wrote. The study, “Using former carers’ expertise in peer support for…

FB-101, an experimental oral therapy that 1ST Biotherapeutics is developing as a treatment for Parkinson’s disease, was well-tolerated in the first part of a Phase 1 clinical trial in healthy volunteers, the company announced. In the trial of (NCT04165837), which is being conducted in Baltimore,  24 adults…

A transplant of stem cell-derived nerve cells engineered to produce a signaling factor that promotes nerve health was shown to lessen motor deficits and increase dopamine activity in a rat model of Parkinson’s disease. The signaling factor, BDNF, is seen as a potentially effective treatment for Parkinson’s. While…

People with Parkinson’s disease who show early dysfunction in the nerves controlling heartbeat tend to experience faster disease progression, a new study shows. According to researchers, these results support a new approach differentiating “brain-predominant” Parkinson’s from disease with “body-involvement.” “These findings correspond well to the results of…

Ventus Therapeutics and Novo Nordisk have agreed to work together to develop new anti-inflammatory medicines that may be useful in Parkinson’s disease and other disorders, the companies announced. “This is an important collaboration for Ventus that validates our structural biology capabilities to discover and develop highly differentiated…

Parkinson’s patients with a postural abnormality called Pisa syndrome show deficits in their ability to process visual and balance-related information, a new study done using virtual reality suggests. “The visual tilting perception assessed in our study is a visual domain task, and our study revealed that [Pisa syndrome]…